A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine

BACKGROUND: Chronic migraine (CM) is problematic, and there are few effective treatments. Recently, it has been hypothesized that glial activation may be a contributor to migraine; therefore, this study investigated whether the potential glial inhibitor, ibudilast, could attenuate CM. METHODS: The s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwok, Yuen H, Swift, James E, Gazerani, Parisa, Rolan, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096778/
https://www.ncbi.nlm.nih.gov/pubmed/27826212
http://dx.doi.org/10.2147/JPR.S116968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096778/
https://www.ncbi.nlm.nih.gov/pubmed/27826212
http://dx.doi.org/10.2147/JPR.S116968

Ejemplares similares